| 4:00–8:00 PM | Arrival and Registration | Courtyard by Marriott Marin Room | 
| 6:00–8:00 PM | Welcome Mixer | Courtyard by Marriott Marin Room | 
| 7:45–8:30 AM | Shuttle to Buck Institute | Courtyard by Marriott Front Desk | 
| 8:00–9:00 AM | Breakfast and Registration | Atrium | 
| 8:30–9:00 AM | Poster Setup | Atrium | 
| 9:00–9:30 AM | Welcome Address from the Organizers | Drexler Auditorium | 
| Bei B. Zhang, Novo Nordisk NovoNordisk  | 
            
| Teresa Zimmers, Oregon Health and Science University Knight Cancer Institute Oregon Health and Science University  | 
            
| 9:00–7:00 PM | Poster Viewing | Atrium | 
| 9:30–12:15 PM | Defining Cachexia as a Disease within a Disease | Drexler Auditorium | 
| * Bette Caan, Kaiser Permanente Session Chair  | 
            
| * Denis C. Guttridge, Medical University of South Carolina Session Chair  | 
            
| Vickie Baracos, University of Alberta Clinical Classification of Cancer Cachexia  | 
            
| Stefan D. Anker, Charité Universitätsmedizin Berlin Cardiac Dysfunction and Wasting at the Heart of Cachexia  | 
            
| Mariam Jamal-Hanjani, University College London Insights Into Lung Cancer-Associated Cachexia From the TRACERx Study  | 
            
| Laure Bindels, Université Catholique de Louvain Contribution and Therapeutic Prospects from the Gut Microbiome to Cancer Cachexia  | 
            
| 10:30–10:50 AM | Coffee Break | Atrium | 
| 12:15–1:15 PM | Lunch | Atrium | 
| 1:00–3:00 PM | Poster Session 1 | Atrium | 
| 3:00–3:30 PM | Coffee Available | Atrium | 
| 3:30–5:30 PM | Delineating Underlying Biological Pathways | Drexler Auditorium | 
| * David J. Glass, Regeneron Pharmaceuticals, Inc. Session Chair  | 
            
| * Mariam Jamal-Hanjani, University College London Session Chair  | 
            
| Teresa Zimmers, Oregon Health and Science University Knight Cancer Institute Organ Crosstalk in Cachexia  | 
            
| Tony Tony Hui, Harvard T.H. Chan School of Public Health Energy Metabolism in Cachexia - Quantitative Fluxomics  | 
            
| Denis C. Guttridge, Medical University of South Carolina Muscle Microenvironment in Cancer Cachexia  | 
            
| Andrea Graziani, Università di Torino Short Talk: Short Talk: Impaired cAMP/CREB1 Signaling Drives Mitochondrial Dysfunction in Skeletal Muscle During Cancer Cachexia  | 
            
| Maria Rohm, Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt Short Talk: Short Talk: Cancer Cachexia Causes Impaired CD8+ T Cell Activation and Lymphopenia that Contributes to Tissue Wasting  | 
            
| 5:30–5:35 PM | Introduction of the Cancer Cachexia Society | Drexler Auditorium | 
| Andrea Bonetto, University of Colorado Anschutz Medical Campus | 
            
| 5:35–8:00 PM | On Own for Dinner | 
| 8:00–9:00 PM | Dessert Social Hour with Trivia | Courtyard by Marriott Marin Room | 
| 7:45–8:30 AM | Shuttle to Buck Institute | Courtyard by Marriott Front Desk | 
| 8:00–9:00 AM | Breakfast | Atrium | 
| 8:30–9:00 AM | Poster Setup | Atrium | 
| 9:00–12:00 PM | Cachexia in Chronic Illness | Drexler Auditorium | 
| * Danna M. Breen, Pfizer Inc. Session Chair  | 
            
| * Laure Bindels, Université Catholique de Louvain Session Chair  | 
            
| Marcus D. Goncalves, Weill Cornell Medicine Cachexia and Cancer  | 
            
| Philip A. Efron, University of Florida Persistent Inflammatory/Immunosuppressive Catabolic Syndrome (PICS) after Sepsis  | 
            
| David J. Glass, Regeneron Pharmaceuticals, Inc. Cachexia and COVID-19  | 
            
| Marilia C Seelaender, University of São Paulo Adipose Tissue Role in Acute COVID-19 and Long COVID Syndrome: A New Form of Cachexia?  | 
            
| Shinpei Kawaoka, Tohoku University / Kyoto university Short Talk: Short Talk: Systemic Metabolic and Immune Defects in Advanced Cancer Patients Prior to the Onset of Pre-Cachexia  | 
            
| Aliesha Garrett, Terasaki Institute for Biomedical Innovation Short Talk: Short Talk: Vagal Perturbation of the Liver-Brain Axis Deters Cancer-Associated Cachexia Independent of Tumor Burden  | 
            
| 9:00–7:00 PM | Poster Viewing | Atrium | 
| 10:00–10:20 AM | Coffee Break | Atrium | 
| 12:00–1:00 PM | Lunch | Atrium | 
| 12:30–2:30 PM | Poster Session 2 | Atrium | 
| 2:30–4:30 PM | Workshop | Drexler Auditorium | 
| * Tony Tony Hui, Harvard T.H. Chan School of Public Health Session Chair  | 
            
| * Rodney Infante, University of Texas Southwestern Medical School Session Chair  | 
            
| Houda Cohen, University of Minnesota Chronic Cardiac Wasting-Associated Cardiomyopathy in Post-Tumor-Mediated Cancer Cachexia  | 
            
| Anja Karlstaedt, Cedars Sinai Medical Center D2-HG Promotes IDH-Mutant Cancer-Associated Autophagic Proteolysis Skeletal Muscle  | 
            
| Hassan Fakih, UMass Chan Medical School Efficacious and Durable Myostatin Knockdown Using Chemically Optimized siRNAs  | 
            
| Hong-Wen Tang, Duke-NUS Medical School Deaf1 Regulates Muscle Regeneration through Autophagy  | 
            
| Muhannad Abu-Remaileh, Dana Farber Cancer Institute Roles of HIF2 and PTHLH in Kidney Cancer-Associated Cachexia: Treatment with a First-In-Class Agent  | 
            
| Venise Jan Castillon, Memorial Sloan Kettering Cancer Center Systemic Physiological Changes Indicative of Cancer Cachexia at Diagnosis  | 
            
| Justin L Shahtout, University of Utah Targeting Skeletal Muscle Lipid Hydroperoxides in Cancer Cachexia  | 
            
| Paige Arneson-Wissink, OHSU PDAC Recovery Associates with Impaired Hepatic metabolism, Delayed Muscle Recovery, and Decreased Activity Levels  | 
            
| 4:30–5:00 PM | Coffee Available | Atrium | 
| 5:00–7:00 PM | Approaches to Therapeutic Intervention | Drexler Auditorium | 
| * Marcus D. Goncalves, Weill Cornell Medicine Session Chair  | 
            
| * Vickie Baracos, University of Alberta Session Chair  | 
            
| Steven Heymsfield, Pennington Biomedical Research Center Digital Technology for Body Weight Phenotyping  | 
            
| Rodney Infante, University of Texas Southwestern Medical School Harnessing Cachexia Mechanisms to Elucidate Tumor-directed Therapies  | 
            
| Danna M. Breen, Pfizer Inc. GDF15/Ponsegromab: A Potential Treatment for Cachexia  | 
            
| Kate Orlowsky, AVEO Oncology Short Talk: Short Talk: A Phase 1b Dose Escalation Study of AV-380 in Combination with Standard of Care Chemotherapy in Metastatic Cancer Patients (pts) with Cachexia and Elevated GDF-15 Levels  | 
            
| Andrei Turtoi, INSERM Cancer Research Institute of Montpellier, France Short Talk: Short Talk: Nozomitumab: A Potential Treatment for Prevention of Cancer-Induced Cachexia via Reprogramming Macrophage Function in Adipose and Muscle Tissues  | 
            
| 7:00–8:00 PM | On Own for Dinner | 
| 7:45–9:30 PM | Transportation to Novato for Dinner | Courtyard by Marriott Front Desk |